Multidisciplinary Association for Psychedelic Studies (MAPS)
GPTKB entity
Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:non-profit_organization
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Rick_Doblin
|
| gptkbp:advocates_for |
drug policy reform
psychedelic therapy |
| gptkbp:clinical_trial |
LSD research
Ayahuasca research Ibogaine research Ketamine research Phase 1 trials for MDMA Phase 2 trials for MDMA Phase 3 trials for MDMA Psilocybin research |
| gptkbp:collaborates_with |
research institutions
|
| gptkbp:community_engagement |
social media campaigns
community outreach educational outreach advocacy campaigns media relations |
| gptkbp:educational_programs |
workshops
|
| gptkbp:events |
conferences
|
| gptkbp:focus |
psychedelic research
|
| gptkbp:founded |
gptkb:1986
|
| gptkbp:founder |
gptkb:Rick_Doblin
|
| gptkbp:headquarters |
gptkb:Santa_Cruz,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Multidisciplinary Association for Psychedelic Studies (MAPS)
|
| gptkbp:impact |
mental health treatment
clinical practice guidelines for psychedelics drug policy reform advocacy public awareness of psychedelics research funding for psychedelics |
| gptkbp:mission |
develop medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics
|
| gptkbp:notable_work |
MDMA-assisted psychotherapy
|
| gptkbp:partnerships |
government agencies
|
| gptkbp:publishes |
peer-reviewed articles
|
| gptkbp:receives_funding_from |
donations
|
| gptkbp:research |
clinical trials
|
| gptkbp:research_areas |
gptkb:historical_event
gptkb:drug mental health anxiety trauma chronic pain PTSD substance use disorders psychological distress end-of-life anxiety |
| gptkbp:website |
maps.org
|